18 and older, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants That Successfully Used FitMi PD to Exercise at HomePrimary· Immediately Post-Treatment, an average of 3 weeks
Number of participants who were successfully able to use the device at home to exercise over 3 week period.
Group
Value
95% CI
At Home Exercise Therapy With FitMi PD
7
Mini Mental State Examination (MMSE)Secondary· Baseline
A screening tool for assessing cognitive impairment. A maximum possible score of 30 is used to provide a picture of an individuals' present cognitive performance. A score of \< 24 is the generally accepted cutoff indicating the presence of cognitive impairment.
Levels of impairment have been classified as:
None: score = 24-30 Mild: score = 18-24 Severe: score = 0-17
Group
Value
95% CI
At Home Exercise Therapy With FitMi PD
30
± 0.44
Sponsor's own description
The investigators will run an at-home usability study of a newly developed home exercise device (FitMi PD) for individuals with Parkinson's disease. FitMi PD uses embedded sensors that can track and record the user's direction and degree of movement while performing exercises described on a computer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07399496 — Accelerated TMS for Apathy in PD
· NA
· recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
· Phase 1
· recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients
· NA
· recruiting
NCT06848205 — Percept Transitions in FOG and PD
· NA
· recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P
· Phase 2
· recruiting
Other Flint Rehabilitation Devices, LLC trials
Trials by the same sponsor.
NCT06752707 — MiGo Tracker Remote Monitoring of Home Exercise After Stroke
· NA
· recruiting
NCT05504811 — FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
· NA
· completed
NCT03935425 — FitMi Plus Home Therapy for Stroke Patients
· NA
· completed
NCT04471935 — Speech Hero Home Therapy for Aphasia
· NA
· completed
NCT03503617 — RehabTouch Home Therapy for Stroke Patients
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Flint Rehabilitation Devices, LLC
Last refreshed: 17 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05655377.